Bioaffinity Technologies Inc (BIAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,910 | -9,040 | -7,937 | -8,154 | -6,326 |
| Depreciation Amortization | 505 | 606 | 250 | 2,066 | 485 |
| Accounts receivable | 597 | -328 | 311 | -9 | N/A |
| Accounts payable and accrued liabilities | -225 | 383 | -15 | 115 | 39 |
| Other Working Capital | 594 | 180 | 901 | 114 | 633 |
| Other Operating Activity | 4,110 | 935 | 452 | 1,798 | 3,120 |
| Operating Cash Flow | $-9,329 | $-7,265 | $-6,038 | $-4,071 | $-2,049 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -61 | -79 | -23 | -220 | N/A |
| Net Acquisitions | N/A | N/A | -2,187 | N/A | N/A |
| Investing Cash Flow | $-61 | $-79 | $-2,209 | $-220 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -45 | 192 | N/A | 1,279 | 3,507 |
| Debt Repayment | -324 | -361 | -93 | N/A | N/A |
| Common Stock Issued | 15,886 | 7,059 | N/A | 13,816 | N/A |
| Other Financing Activity | -782 | -1,262 | -252 | -751 | -181 |
| Financing Cash Flow | $14,734 | $5,628 | $-345 | $14,344 | $3,327 |
| Beginning Cash Position | 1,105 | 2,822 | 11,414 | 1,361 | 83 |
| End Cash Position | 6,450 | 1,105 | 2,822 | 11,414 | 1,361 |
| Net Cash Flow | $5,345 | $-1,716 | $-8,592 | $10,053 | $1,278 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,329 | -7,265 | -6,038 | -4,071 | -2,049 |
| Capital Expenditure | -61 | -79 | -23 | -220 | N/A |
| Free Cash Flow | -9,389 | -7,344 | -6,061 | -4,291 | -2,049 |